Cutaneous biology of γδ T cells

Advances in Dermatology

Volumn 20, Issue , 2004, Pages 203-215

  Girardi, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; LYMPHOCYTE ANTIGEN RECEPTOR;

CANCER GROWTH; CARCINOGENESIS; CELL FUNCTION; CELL INFILTRATION; CELL ISOLATION; CELL PROLIFERATION; CELL PROTECTION; CELLULAR DISTRIBUTION; CLINICAL TRIAL; CYTOLOGY; DERMATITIS; GENE MUTATION; GENE REARRANGEMENT; HELPER CELL; HUMAN; IMMUNOREGULATION; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; REVIEW; SKIN; SKIN CANCER; T LYMPHOCYTE ACTIVATION; IMMUNOLOGY; INFLAMMATION; SKIN DISEASE; T LYMPHOCYTE;

HUMANS; INFLAMMATION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SKIN DISEASES; T-LYMPHOCYTES;

EID: 16544387415     PISSN: 08820880     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (28)

1. Janeway CA, Travers P, Walport M, et al: Immunobiology: The Immune System in Health and Disease. New York, Garland Publishing, 2001.
2. Hayday A, Theodoridis E, Ramsburg E, et al: Intraepithelial lymphocytes: Exploring the Third Way in immunology. Nat Immunol 2:997-1003, 2001.
3. The term "surge protector" applied as a metaphor for γδ T-cell regulation of inflammation was first heard by the author mentioned by H. Kirk Ziegler, PhD.
4. Fisch P, Malkovsky M, Kovats S, et al: Recognition by human V gamma 9/V delta 2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. Science 250:1269-1273, 1990.
5. Kato Y, Tanaka Y, Miyagawa F, et al: Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens. J Immunol 167:5092-5098, 2001.
6. Fisch P, Meuer E, Pende D, et al: Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity. Eur J Immunol 27:3368-3379, 1997.
7. Wilhelm M, Kunzmann V, Eckstein S, et al: Gammadelta T cells for immune therapy of patients with lymphoid malignancies. Blood 102:200-206, 2003.
8. Kunzmann V, Bauer E, Feurle J, et al: Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 96:384-392, 2000.
9. Groh V, Rhinehart R, Secrist H, et al: Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci U S A 96:6879-6884, 1999.
10. Bergstresser PR, Sullivan S, Streilein JW, et al: Origin and function of Thy-1+ dendritic epidermal cells in mice. J Invest Dermatol 85:85S-90S, 1985.
11. Roberts SJ, Smith AL, West AB, et al: T-cell alpha beta + and gamma delta + deficient mice display abnormal but distinct phenotypes toward a natural, widespread infection of the intestinal epithelium. Proc Natl Acad Sci U S A 93:11774-11779, 1996.
12. Dalton JE, Pearson J, Scott P, et al: The interaction of gamma delta T cells with activated macrophages is a property of the V gamma 1 subset. J Immunol 171:6488-6494, 2003.
13. Mukasa A, Yoshida H, Kobayashi N, et al: Gamma delta T cells in infection-induced and autoimmune-induced testicular inflammation. Immunology 95:395-401, 1998.
14. Girardi M, Lewis J, Glusac E, et al: Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation. J Exp Med 195:855-867, 2002.
15. Hayday A, Tigelaar R: Immunoregulation in the tissues by gammadelta T cells. Nat Rev Immunol 3:233-242, 2003.
16. Van Damme N, De Keyser F, Demetter P, et al: The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome. Clin Exp Immunol 125:383-390, 2001.
17. Dunn GP, Bruce AT, Ikeda H, et al: Cancer immunoediting: From immunosurveillance to tumor escape. Nat Immunol 3:991-998, 2002.
18. Girardi M, Oppenheim D, Lewis J, et al: Characterizing the protective component of the γδ T cell response to transplantable squamous cell carcinoma. J Invest Dermatol 122:699-706, 2004.
19. Coulie PG, Karanikas V, Colau D, et al: A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3. Proc Natl Acad Sci U S A 98:10290-10295, 2001.
20. Sivinski CL, Kohlgraf KG, VanLith ML, et al: Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: Implications for tumor vaccines. Cancer Immunol Immunother 51:327-340, 2002.
21. Girardi M, Oppenheim DE, Steele CR, et al: Regulation of cutaneous malignancy by gammadelta T cells. Science 294:605-609, 2001.
22. Gao Y, Yang W, Pan M, et al: Gamma delta T cells provide an early source of interferon gamma in tumor immunity. J Exp Med 198:433-442, 2003.
23. + T cells to different stages of chemically induced skin cancer. J Exp Med 198:747-755, 2003.
24. Owens DM, Wei S, Smart RC: A multihit, multistage model of chemical carcinogenesis. Carcinogenesis 20:1837-1844, 1999.
25. Kaminski MJ, Cruz PD Jr, Bergstresser PR, et al: Killing of skin-derived tumor cells by mouse dendritic epidermal T-cells. Cancer Res 53:4014-4019, 1993.
26. Holtmeier W, Pfander M, Zollner TM, et al: Distinct TCR delta repertoires are present in the cutaneous lesions and inflamed duodenum of patients with dermatitis herpetiformis. Exp Dermatol 11:527-531, 2002.
27. Pardoll DM: Immunology. Stress, NK receptors, and immune surveillance. Science 294:534-536, 2001.
28. Kabelitz D, Wesch D: Features and functions of γδ T lymphocytes: Focus on chemokines and their receptors. Crit Rev Immunol 23:339-370, 2003.